Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma (Q33366403)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma |
scientific article |
Statements
1 reference
Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma (English)
1 reference
Dieter Hoelzer
1 reference
Mathias J Rummel
1 reference
Salah E Al-Batran
1 reference
Soo-Z Kim
1 reference
Manfred Welslau
1 reference
Ralf Hecker
1 reference
Dorothea Kofahl-Krause
1 reference
Klaus-M Josten
1 reference
Heinz Dürk
1 reference
Andreas Rost
1 reference
Michael Neise
1 reference
Ulrich von Grünhagen
1 reference
Kai U Chow
1 reference
Martin-L Hansmann
1 reference
Paris S Mitrou
1 reference
1 May 2005
1 reference
1 reference
23
1 reference
15
1 reference
3383-3389
1 reference
Identifiers
1 reference
1 reference